English Deutsch 中文
  • Innovative Solutions
  • Expert Support and Knowledge
  • Reliable Cooperation
Menu Deutsch 中文

ShangPharma Listed on NYSE

Oct. 18, 2010

China-based ShangPharma, one of China's largest contract research organizations, made its debut on the New York Stock Exchange on October 19, 2010.
Based on an initial public offering at $15 per share, the company managed to raise $87 million from which it is expected to receive net proceeds of about $45 million.